benzoxazoles has been researched along with Carcinoma, Lewis Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akita, S; Fujitaka, K; Haruta, Y; Hattori, N; Ishikawa, N; Kohno, N; Masuda, T; Murai, H; Senoo, T | 1 |
1 other study(ies) available for benzoxazoles and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Benzoxazoles; Carcinoma, Lewis Lung; Cell Line, Tumor; Dicarboxylic Acids; Disease Progression; Gene Knockdown Techniques; HEK293 Cells; Human Umbilical Vein Endothelial Cells; Humans; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neovascularization, Pathologic; Plasminogen Activator Inhibitor 1 | 2013 |